0001415889-24-007681.txt : 20240312
0001415889-24-007681.hdr.sgml : 20240312
20240312172545
ACCESSION NUMBER: 0001415889-24-007681
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240309
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saad Kareem
CENTRAL INDEX KEY: 0001873805
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39482
FILM NUMBER: 24743490
MAIL ADDRESS:
STREET 1: C/O SEMA4 HOLDINGS CORP
STREET 2: 333 LUDLOW STREET, NORTH TOWER, 8TH FL.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneDx Holdings Corp.
CENTRAL INDEX KEY: 0001818331
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 851966622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 617 780 8742
MAIL ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Sema4 Holdings Corp.
DATE OF NAME CHANGE: 20210721
FORMER COMPANY:
FORMER CONFORMED NAME: CM Life Sciences, Inc.
DATE OF NAME CHANGE: 20200715
4
1
form4-03122024_090335.xml
X0508
4
2024-03-09
0001818331
GeneDx Holdings Corp.
WGS
0001873805
Saad Kareem
C/O GENEDX HOLDINGS CORP.
333 LUDLOW ST, NORTH TOWER
STAMFORD
CT
06902
false
true
false
false
CHIEF TRANSFORMATION OFFICER
0
Class A Common Stock
2024-03-09
4
M
0
2841
0
A
27308
D
Restricted Stock Unit
2024-03-09
4
M
0
2841
0
D
Class A Common Stock
2841
31249
D
Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
/s/ Devin Schaffer, Attorney-in-Fact
2024-03-12